Acknowledgement
Supported by : 한국학술진흥재단
References
- Lau JY, Wright TL: Molecular virology and pathogenesis of hepatitis B. Lancet 342;1335-1340, 1993 https://doi.org/10.1016/0140-6736(93)92249-S
- Ganem D: Hepadnaviridae and their replication. In: Fields BN eds.: Fields virology 3rd ed. p1199-1233, Philadelphia Lippincott-Raven, 1996.
- Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J: Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 119;312-323, 1993 https://doi.org/10.7326/0003-4819-119-4-199308150-00011
- Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Jr., Lindsay K, Payne J: A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med 323;295-301, 1990 https://doi.org/10.1056/NEJM199008023230503
- Krogsgaard K, Bindslev N, Christensen E, Craxi A, Schlichting P, Schalm S: The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep). J Hepatol 21;646-655, 1994 https://doi.org/10.1016/S0168-8278(94)80114-2
- Lai CL, Ching CK, Tung AK, Li E, Young J, Hill A: Lamivudine is effective in Suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology 25;241-244, 1997 https://doi.org/10.1002/hep.510250144
- Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, Condreay LD, Tzakis AG, Schiff ER, Brown NA: Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 4;349:20-22, 1997 https://doi.org/10.1016/S0140-6736(96)02266-0
- Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL: Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24;714-717, 1996
- Blum HE, Galun E, von Weizsacker F, Wands JR: Inhibition of hepatitis B virus by antisense oligodeoxynucleotides. Lancet 337;1230, 1991
- Offensperger WB, Offensperger S, Walter E, Teubner K, Igloi G, Blum HE, Gerok W: In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO J 12;1257-1262, 1993
- Carman W, Thomas H, Domingo E: Viral genetic variation:hepatitis B virus as a clinical example. Lancet 341;349-353, 1993 https://doi.org/10.1016/0140-6736(93)90146-8
- von Weizsacker F, Wieland S, Kock J, Offensperger WB, Offensperger S, Moradpour D: Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants. Hepatology 26;251-255, 1997 https://doi.org/10.1002/hep.510260237
- Winter G, Milstein C: Man-made antibodies. Nature 349;293-299, 1991 https://doi.org/10.1038/349293a0
- McCafferty J, Griffiths AD, Winter G, Chiswell DJ: Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348;552-554, 1990 https://doi.org/10.1038/348552a0
- Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM: Single-chain antigen-binding proteins. Science 242;423-426, 1998.
- Radziwill G, Tucker W, Schaller H. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol 64;613-620, 1990
- Barbas CF III, Burton DR, Scott JK, Silverman GJ: Phage display, a laboratory manual. p9.23-11.15 CSHL press, 2001
- Tsurimoto T, Fujiyama A, Matsubara K: Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl Acad Sci USA 84:444-448, 1987 https://doi.org/10.1073/pnas.84.2.444
- Jeong JH, Kwak DS, Rho HM, Jung G: The catalytic properties of human hepatitis B virus polymerase. Biochem Biophys Res Commun 223:264-271, 1996 https://doi.org/10.1006/bbrc.1996.0882
- Seifer M, Standring DN: Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin, DR1. J Virol 67;4513-4520, 1993
- Winter G, Harris WJ: Humanized antibody. Immunol Today 14;139-143, 1993
- Andrzejewski C, Young PJ, Goldman J: Production of human IgM warm reacting red cell monoclonal autoantibodies by Epstein-Barr virus transformation. Transfusion 101;196-202, 1989
- Lonberg N, Taylor LD, Harding FA: Antigen-specific human antibodies from mice comprising four distinct modifications. Nature 368;856-859, 1994 https://doi.org/10.1038/368856a0
- Winter G, Griffiths AD, Hawkins RE: Making antibodies by phage display technology. Ann Rev Immunol 12:433-455, 1994 https://doi.org/10.1146/annurev.iy.12.040194.002245
- Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G: By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222;581-597, 1991 https://doi.org/10.1016/0022-2836(91)90498-U
- Clackson T, Hoogenboom HR, Griffiths AD, Winter G: Making antibody fragments using phage display libraries. Nature 352:624-628, 1991. https://doi.org/10.1038/352624a0
- Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL: Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 13;3245-3260, 1994.
- Malmborg AC, Duenas M, Ohlin M, Soderlind E, Borrebaeck CA: Selection of binders from phage displayed antibody libraries using the BIAcore biosensor. J Immunol Methods 198;51-57, 1996 https://doi.org/10.1016/0022-1759(96)00159-7
- Hawkins RE, Russell SJ, Winter G: Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol 226;889-896, 1992 https://doi.org/10.1016/0022-2836(92)90639-2
- Bradbury A, Persic L, Werge T, Cattaneo A: Use of living columns to select specific phage antibodies. Biotechnology (NY) 11;1565-1569, 1993 https://doi.org/10.1038/nbt1293-1565
- Cai X, Garen A: Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries. Proc Natl Acad Sci USA 92;6537-6541, 1995 https://doi.org/10.1073/pnas.92.14.6537
- Van Ewijk W, de Kruif J, Germeraad WT, Berendes P, Ropke C, Platenburg PP, Logtenberg T: Subtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments. Proc Natl Acad Sci USA 94;3903-3908, 1997 https://doi.org/10.1073/pnas.94.8.3903